                         SEQUENCE LISTING

<110>  Fresenius Kabi iPSUM Srl
 
<120>  Process for the manufacture of icatibant

<130>  FK17137-04-PAT-WO

<150>  EP18168558
<151>  2018-04-20

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  equivalent of a fragment of icatibant (amino acid moieties 1-5 of
       icatibant) containing only L-amino acid moieties


<220>
<221>  Xaa
<222>  (4)..(4)
<223>  4-hydroxyproline

<400>  1

Arg Arg Pro Xaa Gly 
1               5   


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  fragment of icatibant (amino acid moieties 2-5 of icatibant)


<220>
<221>  Xaa
<222>  (3)..(3)
<223>  4-hydroxyproline

<400>  2

Arg Pro Xaa Gly 
1               

